FDA approves a subcutaneous formulation of Genentechs Actemra (tocilizumab) for treating active polyarticular juvenile idiopathic arthritis in patient...
Federal Register notice: FDA announces a partial withdrawal of a proposed rule published in the 8/21/2003 Federal Register that would have amended the...
FDA clears a Baxter International 510(k) for the Spectrum IQ Infusion System with Dose IQ Safety Software.
FDA approves a UCB supplemental NDA for Briviact (brivaracetam) CV oral formulations indicated as monotherapy and adjunctive therapy in treating parti...
FDA grants Immunicom a breakthrough device designation for its Immunopheresis therapy, which is based on a proprietary technology that selectively rem...
HHS secretary Alex Azar, a former top Lilly executive, vows to use his shocking amount of power to force drug prices down, mirroring objectives of FDA...
Federal Register notice: FDA makes available a draft entitled Pediatric HIV Infection: Drug Development for Treatment.
FDA Review posts the Federal Register notices for the week ending 5/11/2018.